Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 1/20 | 0.47 |
| ▸ | GRM2 | Q14416 | 14/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5107804 | 1.00 | F10 (0.47) | F10GRM2MAOB | |
| SCHEMBL5998598 | 0.91 | F10 (0.49) | F10GRM2MAOB | |
| SCHEMBL5115309 | 0.90 | F10 (0.48) | F10GRM2MAOB | |
| SCHEMBL5115299 | 0.90 | F10 (0.48) | F10GRM2MAOB | |
| Hydrochloric Acid SCHEMBL5506711 | 0.90 | F10 (0.48) | F10GRM2MAOB | |
| Hydrochloric Acid SCHEMBL5506708 | 0.90 | F10 (0.48) | F10GRM2MAOB | |
| SCHEMBL5113182 | 0.85 | F10 (0.47) | F10GRM2MAOB | |
| SCHEMBL5113186 | 0.85 | F10 (0.47) | F10GRM2MAOB | |
| SCHEMBL5507922 | 0.84 | MAOA (0.47) | F10GRM2MAOB | |
| SCHEMBL5507911 | 0.84 | MAOA (0.47) | F10GRM2MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080262056-A1 | Oxindole Oxazolidinones as Antibacterial Agents | PFIZER INC | 2008-10-23 | — | — | US | disclosed |
| US-20060229348-A1 | Oxindole oxazolidinone as antibacterial agent | JOSYULA VARA PRASAD V N | 2006-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060229348-A1 | Oxindole oxazolidinone as antibacterial agent | OXA1L, MRPL21, RPS27L | F10 1720/4885GRM2 3560/4885MAOB 1778/4885 |
| US-20080262056-A1 | Oxindole Oxazolidinones as Antibacterial Agents | OXA1L, OXSR1, OXER1 | F10 784/4885GRM2 3782/4885MAOB 412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.